Surveillance decision

Surveillance decision

We will not update the guideline on managing medicines in care homes at this time.

A number of editorial corrections were identified. See appendix A: summary of new evidence for details.

Reason for the decision

We found a total of 25 pieces of new evidence, including 16 policies or reports and 9 primary studies, as well as 2 pieces of ongoing research. None of the new evidence assessed was considered to have an impact on current recommendations. See appendix A: summary of evidence from surveillance for further details.


This page was last updated: 14 December 2017